Valneva
Valneva and Pfizer share positive results from phase 2 trial for Lyme disease vaccine candidate
September 7, 2023Medical Communications Infections and infestations, Pfizer, Vaccine, Valneva, clinical trial, lyme disease
Valneva and Pfizer have announced positive paediatric and adolescent immunogenicity and safety data for their Lyme disease vaccine candidate, VLA15, …
Valneva COVID-19 vaccine deal pulled by UK government
September 13, 2021Research and Development, Sales and Marketing Boris Johnson, Scotland, UK government, Vaccine, Valneva, booster, covid19
Boris Johnson and the UK government have terminated its deal with specialist vaccine company Valneva after it was alleged the …
Valneva’s inactivated COVID-19 vaccine candidate advances to Phase III trial
April 6, 2021Manufacturing and Production COVID-19, COVID-19 vaccine, Valneva, Valneva vaccine, inactivated vaccine
Specialty vaccine company Valneva’s inactivated COVID-19 jab has shown positive results in a Phase I/II trial, with a seroconversion rate …
Valneva begins production of its COVID-19 vaccine
January 28, 2021COVID-19, Valneva
Valneva, a specialty vaccine company focused on the prevention of infectious diseases with significant unmet medical needs, has commenced production …
FDA fast tracks Valneva’s Lyme disease vaccine
August 7, 2017Research and Development, Sales and Marketing Valneva, biotech, life sciences, lyme disease, medicines, pharma, pharmaceutcial
French firm Valneva has announced that its Lyme disease vaccine, known at this stage only by VLA15, has been fast-tracked …
Latest content
FibroFind appoints Lee Borthwick as CEO
July 21, 2026
